SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Artemis Global Life Sciences informs about board meeting

21 Jan 2019 Evaluate

Pursuant to Regulation 29 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Artemis Global Life Sciences has informed that a meeting of the Board of Directors of the company is scheduled to be held on February 4, 2019 (Monday), to consider and approve unaudited financial results (standalone & consolidated) of the company for the quarter ended December 31, 2018. Further the company confirms that as per the company’s Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the company would remain closed for the concerned persons that shall commence from 6:00 PM on January 21, 2019 and will end 48 hours after the results are made public on February 4, 2019.

The above information is a part of company’s filings submitted to BSE.

Artemis Global-Amalg Share Price

51.00 0.00 (0.00%)
22-Oct-2019 18:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×